Joel I. Klein

Lead Independent Director

Mr. Klein has worked for more than 50 years in private industry and government during which time he has gained significant experience in senior policy making and executive roles, as well as a broad range of legal and financial matters.

Mr. Klein is the Senior Advisor to the CEO of Oscar Health Corporation, a health insurance company since 2022 and previously the Chief Policy and Strategy Officer at Oscar from January 2016 to January 2022, and also Chief Executive Officer of Retromer Therapeutics, a biotech start-up, since December 2020. In addition, he is a Director of Juul Labs, since March 2021 and previously served as a Director of News Corporation from January 2011 through November 2020. At News Corporation, Mr. Klein also served as Executive Vice President, Office of the Chairman from June 2003 to December 2015 and Chief Executive Officer of Amplify, the education division of News Corporation, from January 2011 through December 2015.

From 2002 through 2010, Mr. Klein was Chancellor of the New York City Department of Education where he oversaw a system of over 1,600 schools with 1.1 million students, 136,000 employees and a $22 billion budget. He was the U.S. Chairman and Chief Executive Officer of Bertelsmann, Inc. and Chief U.S. Liaison Officer to Bertelsmann AG, a media company, from 2001 to 2002. Mr. Klein also served with the Clinton administration in a number of roles, including Assistant U.S. Attorney General in charge of the Antitrust Division of the U.S. Department of Justice from 1997 until 2000 and Deputy White House Counsel to President Clinton from 1993 to 1995. Mr. Klein entered the Clinton administration after 20 years of public and private legal work in Washington, DC.

Mr. Klein serves on the Boards of The Foundation for Excellence in Education (ExcelinEd) and StudentsFirstNY. He is also on the Advisory Boards of the Zuckerman Mind Brain Behavior Institute and Columbia College.

Mr. Klein received a BA, magna cum laude, from Columbia University and a JD, magna cum laude, from Harvard Law School. He has also received honorary degrees from ten colleges and universities.

Lead Director